(Nasdaq: ETWC), a provider of software and services for electronic clinical trials, is partnering with to expand the reach of its electronic data capture solutions.

The two firms signed a five-year technology transfer agreement under which Ockham, a global contract research and development organization, will use eTrials’ “Trial Intelligence” product.

Financial terms were not disclosed.

Ockham Development Group was acquired in February by ASG Inc. Both companies are based in Cary.

etrials is in the process of being sold. Pennsylvania-based Bio-Imaging last week increased its offer to some $15 million for etrials after an unidentified third company made an unsolicited bit for etrials.

“This joint venture further allows ASG and Ockham to expand our service capabilities and better serve sponsors,” said Ockham President Joshua S. Baker. “The addition of etrials’ adaptive solutions to Ockham’s offering portfolio increases our ability to provide an even greater breadth of integrated solutions with a highly flexible, robust EDC system delivered directly from us.”